Akso Health Net Worth
Akso Health Net Worth Breakdown | AHG |
Akso Health Net Worth Analysis
Akso Health's net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Akso Health's financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Akso Health's overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Akso Health's net worth analysis. One common approach is to calculate Akso Health's market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Akso Health's stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Akso Health's net worth. This approach calculates the present value of Akso Health's future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Akso Health's cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Akso Health's net worth. This involves comparing Akso Health's financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Akso Health's net worth relative to its peers.
Enterprise Value |
|
To determine if Akso Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Akso Health's net worth research are outlined below:
| Akso Health Group is way too risky over 90 days horizon | |
| Akso Health Group may become a speculative penny stock | |
| Akso Health Group appears to be risky and price may revert if volatility continues | |
| The company reported the last year's revenue of 2.41 M. Reported Net Loss for the year was (9.12 M) with profit before taxes, overhead, and interest of 1.27 M. | |
| Akso Health Group has a poor financial position based on the latest SEC disclosures | |
| Latest headline from MacroaxisInsider: Disposition of 429 shares by Monast William E of Akso Health at 19.38 subject to Rule 16b-3 |
Akso Health uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Akso Health Group. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Akso Health's previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
| 13th of October 2023 Upcoming Quarterly Report | View | |
| 30th of June 2023 Next Fiscal Quarter End | View |
Know Akso Health's Top Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Akso Health is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Akso Health Group backward and forwards among themselves. Akso Health's institutional investor refers to the entity that pools money to purchase Akso Health's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Renaissance Technologies Corp | 2024-09-30 | 152.6 K | Geode Capital Management, Llc | 2024-09-30 | 15 K | Rhumbline Advisers | 2024-09-30 | 14.3 K | Blackrock Inc | 2024-09-30 | 2.7 K | Ubs Group Ag | 2024-09-30 | 1.9 K | Millennium Management Llc | 2024-09-30 | 0.0 | Xtx Topco Ltd | 2024-06-30 | 0.0 |
Follow Akso Health's market capitalization trends
The company currently falls under 'Small-Cap' category with a total capitalization of 350.96 M.Market Cap |
|
Project Akso Health's profitablity
| Last Reported | Projected for Next Year | ||
| Return On Tangible Assets | (0.08) | (0.08) | |
| Return On Capital Employed | (0.07) | (0.08) | |
| Return On Assets | (0.08) | (0.08) | |
| Return On Equity | (0.08) | (0.08) |
When accessing Akso Health's net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Akso Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Akso Health's profitability and make more informed investment decisions.
Evaluate Akso Health's management efficiency
Akso Health Group has Return on Asset of (0.0665) % which means that on every $100 spent on assets, it lost $0.0665. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of (0.1238) %, meaning that it generated no profit with money invested by stockholders. Akso Health's management efficiency ratios could be used to measure how well Akso Health manages its routine affairs as well as how well it operates its assets and liabilities. The current Return On Tangible Assets is estimated to decrease to -0.08. The current Return On Capital Employed is estimated to decrease to -0.08. At this time, Akso Health's Total Current Assets are most likely to increase significantly in the upcoming years. The Akso Health's current Fixed Asset Turnover is estimated to increase to 107.59, while Total Assets are projected to decrease to roughly 86.9 M.| Last Reported | Projected for Next Year | ||
| Book Value Per Share | 3.53 | 2.93 | |
| Tangible Book Value Per Share | 3.53 | 3.48 | |
| Enterprise Value Over EBITDA | 3.37 | 3.54 | |
| Price Book Value Ratio | 0.43 | 0.41 | |
| Enterprise Value Multiple | 3.37 | 3.54 | |
| Price Fair Value | 0.43 | 0.41 | |
| Enterprise Value | -36.6 M | -34.8 M |
Examining the leadership quality of Akso Health Group offers valuable insights into its operational efficiency and financial health. This analysis assists investors in making informed decisions regarding the stock.
Enterprise Value Revenue 228.4197 | Revenue | Quarterly Revenue Growth 0.148 | Revenue Per Share | Return On Equity |
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Akso Health insiders, such as employees or executives, is commonly permitted as long as it does not rely on Akso Health's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Akso Health insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Monast William E 3 days ago Disposition of 429 shares by Monast William E of Akso Health at 19.38 subject to Rule 16b-3 | ||
Higby Lawrence M over a month ago Acquisition by Higby Lawrence M of 40000 shares of Akso Health at 16.9375 subject to Rule 16b-3 | ||
Higby Lawrence M over two months ago Disposition of 25000 shares by Higby Lawrence M of Akso Health at 30.4152 subject to Rule 16b-3 | ||
Anido Vicente Jr over three months ago Acquisition by Anido Vicente Jr of 6000 shares of Akso Health at 30.27 subject to Rule 16b-3 | ||
Higby Lawrence M over six months ago Disposition of 50000 shares by Higby Lawrence M of Akso Health at 15.5 subject to Rule 16b-3 | ||
Higby Lawrence M over six months ago Acquisition by Higby Lawrence M of 30100 shares of Akso Health at 0.001 subject to Rule 16b-3 |
Akso Health Earnings per Share Projection vs Actual
Akso Health Corporate Management
| Rui Zhang | Chief Officer | Profile | |
| Yilin Wang | CEO Board | Profile | |
| Ma Xiaoqin | Corporate Secretary | Profile | |
| Daisy Wang | Investor Contact | Profile |
Already Invested in Akso Health Group?
The danger of trading Akso Health Group is mainly related to its market volatility and Company specific events. As an investor, you must understand the concept of risk-adjusted return before you start trading. The most common way to measure the risk of Akso Health is by using the Sharpe ratio. The ratio expresses how much excess return you acquire for the extra volatility you endure for holding a more risker asset than Akso Health. The Sharpe ratio is calculated by using standard deviation and excess return to determine reward per unit of risk. To understand how volatile Akso Health Group is, you must compare it to a benchmark. Traditionally, the risk-free rate of return is the rate of return on the shortest-dated U.S. Treasury, such as a 3-year bond.
When determining whether Akso Health Group is a strong investment it is important to analyze Akso Health's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Akso Health's future performance. For an informed investment choice regarding Akso Stock, refer to the following important reports: Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Akso Health Group. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in rate. You can also try the Transaction History module to view history of all your transactions and understand their impact on performance.
Is Health Care Equipment & Supplies space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Akso Health. If investors know Akso will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Akso Health listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.21) | Revenue Per Share | Quarterly Revenue Growth 0.148 | Return On Assets | Return On Equity |
The market value of Akso Health Group is measured differently than its book value, which is the value of Akso that is recorded on the company's balance sheet. Investors also form their own opinion of Akso Health's value that differs from its market value or its book value, called intrinsic value, which is Akso Health's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Akso Health's market value can be influenced by many factors that don't directly affect Akso Health's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Akso Health's value and its price as these two are different measures arrived at by different means. Investors typically determine if Akso Health is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Akso Health's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.